Matinas BioPharma Holdings, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2013 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Matinas BioPharma Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2013 to Q3 2022.
  • Matinas BioPharma Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $1.41M, a 33.2% increase year-over-year.
  • Matinas BioPharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2018 was $3.83M, a 6.56% increase from 2017.
  • Matinas BioPharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2017 was $3.6M, a 137% increase from 2016.
  • Matinas BioPharma Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2016 was $1.52M, a 4.59% decline from 2015.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.41M +$352K +33.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q3 2021 $1.06M +$1.06M +111233% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q3 2020 $953 +$282 Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $945 +$123 Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.45K +$643 Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q3 2019 $1.03M $671* -$504K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.54M $822* -$549K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.09M $804* -$1.75M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $3.83M $1.03M -$328K -24.2% Oct 1, 2018 Dec 31, 2018 10-K 2019-04-01
Q3 2018 $4.16M $505K -$46K -8.35% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $4.21M $550K +$234K +74.1% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $3.97M $1.75M +$376K +27.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $3.6M $1.36M +$1.11M +454% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $2.48M $551K +$71K +14.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.41M $316K -$85K -21.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $2.5M $1.37M +$979K +249% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $1.52M $245K -$119K -32.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $1.64M $480K -$14K -2.83% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.65M $401K $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $1.65M $393K +$60K +18% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.59M $364K -$162K -30.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $1.75M $494K -$406K -45.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $2.16M $401K +$127K +46.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $2.03M $333K +$59K +21.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $1.97M $526K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $900K +$722K +406% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $274K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $274K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 $178K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.